Yes, in his case, waiting 5 years for the "all clear" is a long time. And unfortunately, I think no matter what treatment there is, that will still be the way to discern this. Watch and observe for several years. Because you figure if they can't operate, more than likely they can't take a sample either. I think NW has found something great, I just wish they would release a little info to clear some things up. I still believe if the efficacy determination was bad, we would have already seen a report on it. I could be wrong, but when it takes this much time, it has to be just a procedural thing. DNDN was successful. Their problems were manufacturing and marketing/pricing. NW seems to have the manufacturing figured out. Hopefully, they won't falter with the marketing/pricing. Germany should be a good test.
Market Data 
Markets 
AI
